Volume 2, Issue 4
مرور بر اساس
ارسال های اخیر
-
First Case of X-linked Recessive Anhidrotic Ectodermal Dysplasia with Immunodeficiency from Iran with Unusual Aspergillus infection
(Research Center For Immunodeficiencies, 2019-12-01)NEMO (NF-κB essential modulator) is a regulatory factor involved in signaling pathways of innate and adaptive immune system. Hypomorphic mutation of IKBKG gene on X chromosome leads to X-linked recessive anhidrotic ectodermal ...
-
NFKB2 mutation in a patient with lymphopenia and extreme cold sensitivity (a case report)
(Research Center For Immunodeficiencies, 2019-12-01)NF-κB pathway is a complex protein playing an important role in regulating lymphocyte development, immune responses, inflammation, cell proliferation, and cell death. The NF-kB signaling pathway has been described to be ...
-
Gastrointestinal Manifestations in Patients with Common Variable Immunodeficiency
(Research Center For Immunodeficiencies, 2019-12-01)Background: Common variable immunodeficiency (CVID) is one of the most prevalent symptomatic primary immunodeficiencies (PIDs), which manifest a wide clinical variability such as gastrointestinal (GI) disorder.Patients ...
-
Autoimmunity in Patients with Hyper IgM Syndrome
(Research Center For Immunodeficiencies, 2019-12-01)Introduction: hyper-IgM (HIGM) syndrome is characterized by normal to increased serum IgM and very low or undetectable IgG, IgA, and IgE. HIGM (also known as class-switch recombination (CSR) defects) patients manifest ...
-
Why should TREC and KREC quantification assay be concerned to screen of newborns in developing countries?
(Research Center For Immunodeficiencies, 2019-12-01)Primary immunodeficiencies contain a group of several different diseases. Giving the fact that their clinical outcome ranges from mild to potentially life-threatening, detection of patients with these diseases in the ...
-
Precision Medicine as Treatment for Primary Immunodeficiency and Immune Dysregulation
(Research Center For Immunodeficiencies, 2019-12-01)“Precision medicine" is the use of therapy that targets the molecular basis of a patient's disease process. This approach is increasingly well-established in treatment of monogenic disorders of immunity, including primary ...



